Armored RNA as virus surrogate in a real-time reverse transcriptase PCR assay proficiency panel

被引:37
作者
Hietala, SK [1 ]
Crossley, BM [1 ]
机构
[1] Univ Calif Davis, Calif Anim Hlth & Food Safety Lab, Davis, CA 95616 USA
关键词
D O I
10.1128/JCM.44.1.67-70.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In recent years testing responsibilities for high-consequence pathogens have been expanded from national reference laboratories into networks of local and regional laboratories in order to support enhanced disease surveillance and to test for surge capacity. This movement of testing of select agents and high-con sequence pathogens beyond reference laboratories introduces a critical need for standardized, noninfectious surrogates of disease agents for use as training and proficiency test samples. In this study, reverse transcription-PCR assay RNA targets were developed and packaged as armored RNA for use as a noninfectious, quantifiable synthetic substitute for four high-consequence animal pathogens: classical swine fever virus; foot-and-mouth disease virus; vesicular stomatitis virus, New Jersey serogroup; and vesicular stomatitis virus, Indiana serogroup. Armored RNA spiked into oral swab fluid specimens mimicked virus-positive clinical material through all stages of the reverse transcription-PCR testing process, including RNA recovery by four different commercial extraction procedures, reverse transcription, PCR amplification, and real-time detection at target concentrations consistent with the dynamic ranges of the existing real-time PCR assays. The armored RNA concentrations spiked into the oral swab fluid specimens were stable under storage conditions selected to approximate the extremes of time and temperature expected for shipping and handling of proficiency panel samples, including 24 h at 37 degrees C and 2 weeks at temperatures ranging from ambient room temperature to -70 degrees C. The analytic test performance, including the reproducibility over the dynamic range of the assays, indicates that armored RNA can provide a noninfectious, quantifiable, and stable virus surrogate for specific assay training and proficiency test purposes.
引用
收藏
页码:67 / 70
页数:4
相关论文
共 17 条
[1]   Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine [J].
Aarthi, D ;
Rao, KA ;
Robinson, R ;
Srinivasan, VA .
BIOLOGICALS, 2004, 32 (03) :153-156
[2]  
BELAK S, 2004, MANUAL DIAGNOSTIC TE
[3]   Generic scheme for independent performance assessment in the molecular biology laboratory [J].
Birch, L ;
English, CA ;
Burns, M ;
Keer, JT .
CLINICAL CHEMISTRY, 2004, 50 (09) :1553-1559
[4]   Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus [J].
Bressler, AM ;
Nolte, FS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) :987-991
[5]  
Bustin Stephen A, 2004, J Biomol Tech, V15, P155
[6]   Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus [J].
Callahan, JD ;
Brown, F ;
Csorio, FA ;
Sur, JH ;
Kramer, E ;
Long, GW ;
Lubroth, J ;
Ellis, SJ ;
Shoulars, KS ;
Gaffney, KL ;
Rock, DL ;
Nelson, WM .
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2002, 220 (11) :1636-1642
[7]   High-throughput real-time RT-PCR assay to detect the Exotic Newcastle Disease Virus during the California 2002-2003 outbreak [J].
Crossley, BM ;
Hietala, SK ;
Shih, LM ;
Lee, L ;
Skowronski, EW ;
Ardans, AA .
JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2005, 17 (02) :124-132
[8]   TaqMan 5′-nuclease human immunodeficiency virus type IPCR assay with phage-packaged competitive internal control for high-throughput blood donor screening [J].
Drosten, C ;
Seifried, E ;
Roth, WK .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (12) :4302-4308
[9]  
Fang X, 2004, JALA, V9, P140
[10]   Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards [J].
Pasloske, BL ;
Walkerpeach, CR ;
Obermoeller, RD ;
Winkler, M ;
DuBois, DB .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (12) :3590-3594